Gender Differences and Diversity in the Treatment of Gastric Cancer and Other Malignancies

Dear Colleagues,

Gastric cancer has declined in recent years but remains the fifth most common cancer in Germany and the second most common worldwide. Over the past few decades, there have been some significant changes in the treatment and therapy. Gastric cancer, once considered difficult to treat with medication, can now be treated with chemotherapy.

This has already made its way into neoadjuvant, adjuvant, and palliative treatment regimens.

There have also been changes in the surgical treatment; metastatic stomach cancer is no longer considered fatal. This, of course, only applies to limited metastases, e.g., oligometastasis of the liver.

There have also been subdivisions into subgroups, for example, with regard to the course of the disease in different age groups. The targeted investigation of specific characteristics in women has so far played a minor role. Evidence of gender differences has been available for some time. Signet ring carcinoma is considered particularly malignant and can have severe and often fatal consequences, especially in young women.

We believe it is time for gender-specific treatment and therapy for women, not only for stomach cancer but for all malignant diseases.

We therefore encourage you to submit your scientific work on the above-mentioned topic.

Prof. Dr. Claus Schildberg
Prof. Dr. Frank Meyer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.